With this background, the present paper aims to qualitatively and quantitatively evaluate for first time, through a systematic review and comprehensive meta-analysis, the available scientific evidence on the clinicopathological and prognostic implications of CCND1 gene amplification and cyclin D1 immunohistochemical protein overexpression in melanomas. The gene discussed is CCND1; the disease is melanoma.